<h1>India Allows 100% Automatic FDI in Medical Devices, Exempting Conditions for Pharma Projects, Effective January 2015.</h1> The Government of India has revised its Foreign Direct Investment (FDI) policy in the pharmaceutical sector, specifically carving out provisions for medical devices. Under the updated policy, 100% FDI is permitted automatically for manufacturing medical devices, exempting them from certain conditions applicable to greenfield and brownfield pharmaceutical projects. A medical device is defined as an instrument or apparatus intended for medical use, excluding pharmacological or metabolic means, and includes accessories and diagnostic devices. This policy change will be effective from January 21, 2015, and aligns with potential amendments to the Drugs and Cosmetics Act.